InMode Ltd. Ordinary Shares (NASDAQ: INMD)
$16.0500
+0.0400 ( +3.08% ) 553.2K
InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions in the United States. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF and Morpheus8. The majority of its revenue comes from the United States.
Market Data
Open
$16.0500
Previous close
$16.0100
Volume
553.2K
Market cap
$1.21B
Day range
$14.8910 - $16.1800
52 week range
$14.8700 - $26.8000
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
6-k | Form 6-K | 3 | Oct 30, 2024 |
6-k | Form 6-K | 3 | Oct 01, 2024 |
6-k | Form 6-K | 4 | Sep 10, 2024 |
6-k | Form 6-K | 3 | Aug 01, 2024 |
6-k | Form 6-K | 3 | May 02, 2024 |
6-k | Form 6-K | 1 | Apr 04, 2024 |
6-k | Form 6-K | 2 | Feb 13, 2024 |
20-f | Annual reports | 110 | Feb 13, 2024 |
6-k | Form 6-K | 4 | Feb 13, 2024 |